Morgan Stanley Maintains Overweight on CVS Health, Raises Price Target to $93

Benzinga · 3d ago
Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $89 to $93.